Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® ScannerWhatever the Disease Area
Investigational drug(s) / intervention(s)
Histolog Scanner
Histolog Scanner: Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture.
Study summary
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥18 years old at the time of consenting
* Undergoing a surgery or a medical procedure with use of Histolog® Scanner
* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
* Active participation in a drug, device, or other medical intervention study that has not reached its primary endpoint at the time of consenting
* Patients under judicial protection, legal guardianship or curatorship.
Primary outcome measure(s)
Number of confirmed medical interventions based on Histolog® image readings. — From enrolment to diagnosis confirmation at post surgery follow-up visit (V2: 37 days after enrolment)
Trial sites (1)
Facility
City
Region
Status
Royal Surrey County Hospital NHS Foundation Trust
Guildford
United Kingdom
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.